Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway

• Xuejiao Liu,
• Yiming Tu,
• Yifeng Wang,
• Di Zhou,
• Yulong Chong,
• Lin Shi,
• Guanzheng Liu,
• Xu Zhang,
• Sijin Wu,
• Huan Li,
• Shangfeng Gao,
• Mingshan Niu,
• Rutong Yu

Affiliations

Xuejiao Liu

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Yiming Tu

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Yifeng Wang

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Di Zhou

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Yulong Chong

Department of Neurosurgery, Suqian Hospital Affiliated to Xuzhou Medical University

Lin Shi

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Guanzheng Liu

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Xu Zhang

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Sijin Wu

College of Pharmacy, The Ohio State University

Huan Li

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Shangfeng Gao

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Mingshan Niu

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University

Rutong Yu

Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University